Investing Profile

Richard Chin

AngelFormer CEOInvestorAdvisor
Seed Investor. Generalist but with preference for crazy ideas in AI, Justice Tech, and Impact Investments
ascendantventure.comSan Francisco, California
Photo of Richard Chin, Managing Director at Ascendant Venture
Harvard University Network
253 CONNECTIONS
Oxford University Network
34 CONNECTIONS
Harvard Medical School Network
20 CONNECTIONS
Genentech Network
12 CONNECTIONS
Genentech Network
12 CONNECTIONS
Ascendant Venture Managing Director
$50K - $1M
$100K
Interested in out-of-the-box, crazy ideas. Generalist but focus on AI, justice tech, biotech, veterinary/pet, impact startups.
Chief Executive Officer Oxigene, Inc.Present
Clinical Associate Professor University of California, San FranciscoPresent
Board Member Balance Therapeutics Inc.Present
Co-Founder and Board Member BioUsawa2023 - Present
Co-Founder and Chairman of the Board of Directors VETmAb Biosciences, Inc.2022 - Present
Co-Founder and Chairman of the Board of Directors AdoraPet Biosciences2022 - Present
Managing Director Ascendant Venture2022 - Present
Board Member Center for Asian American Media2021 - Present
Founder and Chief Executive Officer Infinita Life Science2021 - Present
Board Member Wikitongues2021 - 2023
Founder and Chief Executive Officer KindredBio2012 - 2021
Board Member Caribou Biosciences2013 - 2014
Board Member Genmedica Therapeutics2004 - 2012
Chief Executive Officer Institute for OneWorld Health2008 - 2011
Senior Vice President, Global Development Elan Pharmaceuticals, Inc.2005 - 2006
Senior Vice President, Global Medical Affairs Elan Pharmaceuticals, Inc.2004 - 2005
Head of Clinical Research, Biotherapeutics Unit Genentech2002 - 2004
Head of Clinical Research, Cardiovascular Group Genentech2001 - 2002
Sr. Clinical Scientist Genentech2001 - 2001
Clinical Scientist Genentech1999 - 2001
Harvard Medical School M.D.
Oxford University M.A. (Oxf) Law
Harvard University A.B.